Hoang, Plansky
Wang, Jason
Conklin, Bruce R
Healy, Kevin E
Ma, Zhen
Article History
First Online: 15 March 2018
Competing interests
: B.R.C. is a founder of Tenaya Therapeutics, a company focused on finding treatments for heart failure, including the use of CRISPR interference to interrogate genetic cardiomyopathies. B.R.C. holds equity in Tenaya, and Tenaya provides research support for heart failure-related research to B.R.C. K.E.H. has a financial relationship with Organos Inc., and both he and the company may benefit from commercialization of the results of this research. The other authors declare no competing financial interests.